Christopher Jones, M.D., F.A.C.R., Radiation Oncologist, Sutter Health Medical Group

California Pacific CURRENTS: The online journal of CPMC Research Institute

Leading advances in new radiotherapy techniques to treat cancer; optimizing imaging technologies to predict tumor recurrence and visualize response to therapy

Research Overview

  • Dr. Christopher Jones is a board-certified radiation oncologist who specializes in the use of ionizing radiation to treat cancer, focusing on tumors of the head and neck, prostate, and brain.
  • He investigates optimal use of radiation therapy (radiotherapy) techniques including intensity modulated radiation therapy (IMRT), high-dose brachytherapy, and image-guided radiation therapy.
  • Dr. Jones is a Principal Investigator for Radiation Therapy Oncology Group (RTOG) National Cancer Institute-sponsored oncology group clinical trials.
  • He has authored numerous publications and abstracts on radiotherapy and imaging techniques to assess cancer progression, predict tumor recurrence after surgery and radiotherapy, and visualize response to treatment.
  • Dr. Jones lectures nationally and internationally on the role of radiation therapy in the management of head and neck cancers.

Read more about research among the Sutter Cancer Research Consortium.

Find additional information on oncology research and clinical trials at the Sutter Institute for Medical Research.


Training

Dr. Jones received his M.D. from Rush University in Chicago. He completed residency training in radiation oncology at Massachusetts General Hospital and Harvard Medical School in Boston.


 

Publication Search

Publications

Peacock WF, Baumann BM, Bruton D, Davis TE, Handy B, Jones CW, Hollander JE, Limkakeng AT, Mehrotra A, Than M, Ziegler A, Dinkel C, Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome. JAMA Cardiol

Nichols RC, Hu C, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Gore EM, Balogh AG, McGowan D, Michalski J, Raben A, Rudoler S, Jones CU, Sandler H, Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408. Adv Radiat Oncol

Drury SS, Howell BR, Jones C, Esteves K, Morin E, Schlesinger R, Meyer JS, Baker K, Sanchez MM, Shaping long-term primate development: Telomere length trajectory as an indicator of early maternal maltreatment and predictor of future physiologic regulation. Dev Psychopathol

VIEW ALL
Christopher Jones, M.D., F.A.C.R., Radiation Oncologist, Sutter Health Medical Group
Primary Research Interests
  • Radiotherapy
  • Radiosurgery
  • Cancers of the head and neck, prostate and brain (gliomas)